The 6 W’s: Who, what, where, when, why and what of it… Read more…
An economic analysis carried out by the UK NHS National Innovation Centre identified CYTX’s Celution® System for breast reconstruction Read more…
VSELs may represent the “Holy Grail” of stem cell therapy, a natural “pluripotent”. Read more…
Shares of regenerative medicine stem cell companies were off due to lack of attention of a holiday weekend by Friday, 5/27/11. Read more…
The 6 W’s: Who, what, where, when, why and what of it… Read more…
The 6 W’s: Who, what, where, when, why and what of it… Read more…
Shares of regenerative medicine stem cell companies were resurrected from depreciating markets on Wednesday, 5/25/11. Read more…
The 6 W’s: Who, what, where, when, why and what of it… Read more…
100% of Patients in Study express at least 3 Antigens targeted By ICT-107; validating positive correlation between targeting stem cells and survival Read more…
The 6 W’s: Who, what, where, when, why and what of it… Read more…
Founder and Director of Research, Henry McCusker enters his tenth (10) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.